| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$13 |
Application for quotation of securities - 1AD
|
30 Jan 2026 8:36AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
| Novatti Group Limited (NOV) ORDINARY FULLY PAID |
Information Technology |
$13 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 8:36AM |
$0.031 |
$0.021 |
fallen by
32.26%
|
|
NOV - Price-sensitive ASX Announcement
Full Release
Key Points
- Four consecutive quarters of positive EBITDA in Payments AU/NZ.
- New contract with a tier-one telecommunications company.
- 16% increase in issuing revenue.
- $1 million in growth funding secured.
- AUDC Pty Ltd investment value increased to $16 million.
- Board strengthened with two new non-executive directors.
- Compliance with Australian Accounting Standards confirmed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$97 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 8:36AM |
$0.970 |
$0.635 |
fallen by
34.54%
|
|
BB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- U.S. pilot study achieved 83.7% sensitivity and 84.7% specificity.
- Formal discussions with FDA for pivotal 510(k) study design.
- Expansion of clinical trial network to eight sites in the U.S.
- Received R&D Tax Incentive refund of A$822,205.
- Initiation of pivotal U.S. FDA 510(k) autism study planned for 2026.
- European ADHD study nearing completion with data readout expected soon.
- Strong clinical data and independent scientific validation achieved.
- Financial stability enhanced with A$5.5 million cash balance at quarter-end.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chorus Limited (CNU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$3,597 |
Q2 FY26 Connections Update
|
30 Jan 2026 8:35AM |
$8.160 |
$8.290 |
risen by
1.59%
|
|
| Jade Gas Holdings Limited (JGH) ORDINARY FULLY PAID |
Energy |
$107 |
Quarterly Activities Report & Appendix 5B
|
30 Jan 2026 8:34AM |
$0.028 |
$0.056 |
risen by
100%
|
|
JGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Two production wells online with continuous gas flow.
- Gas composition showed high methane content (>97%).
- Upgrade to site power infrastructure initiated.
- Raised over A$5 million through placement and share purchase plan.
- Cash and financing facilities of A$5.79 million at quarter end.
- Appraisal phase of Red Lake nearing completion.
- A$70 million LOI signed with Langrun for Red Lake development.
- Prepayment towards next well for field expansion made.
- Focused on displacing diesel with gas-produced power.
- Supporting Mongolia's energy transition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ARC Funds Limited (ARC) ORDINARY FULLY PAID |
Financials |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 8:34AM |
$0.115 |
$0.073 |
fallen by
36.52%
|
|
ARC - Price-sensitive ASX Announcement
Full Release
Key Points
- ARC Funds Limited published its quarterly cash flow report for the period ending 31 December 2025.
- The Term Deposit Shop managed over $530 million in funds.
- ARC made a strategic investment in convertible notes of Ausbiz TV Pty Ltd.
- A share placement raised $737,750 for working capital and growth.
- Cash and cash equivalents at the end of the quarter totaled $1,070,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian United Investment Company Limited (AUI) ORDINARY FULLY PAID |
Financials |
$2,378 |
DUI: Proposed merger with AUI
|
30 Jan 2026 8:34AM |
$11.300 |
$10.890 |
fallen by
3.63%
|
|
AUI - Price-sensitive ASX Announcement
Full Release
Key Points
- Proposed merger between DUI and AUI.
- Merger to be implemented by a scheme of arrangement.
- AUI to acquire all DUI shares it does not own.
- Expected higher dividends for DUI shareholders.
- Merger expected to result in a larger investment entity.
- Conditions include shareholder and court approval.
- Merger anticipated to complete by late April 2026.
- Increased dividends and cost savings expected post-merger.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Diversified United Investment Limited (DUI) ORDINARY FULLY PAID |
Financials |
$1,089 |
Proposed merger with AUI
|
30 Jan 2026 8:34AM |
$5.280 |
$5.070 |
fallen by
3.98%
|
|
DUI - Price-sensitive ASX Announcement
Full Release
Key Points
- Proposed merger between DUI and AUI via scheme of arrangement.
- Expected benefits include greater scale, increased dividends, and cost savings.
- Ian Potter Foundation, a major stakeholder, supports the merger.
- Merger is subject to shareholder and Federal Court approvals.
- Customary deal protections included, such as no-shop and break fee.
- Implementation expected by April 2026 with DUI shareholders receiving AUI shares.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Canterbury Resources Ltd (CBY) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 8:33AM |
$0.039 |
$0.040 |
risen by
2.56%
|
|
CBY - Price-sensitive ASX Announcement
Full Release
Key Points
- The document is an Appendix 5B cash flow report for Canterbury Resources Ltd.
- The report provides a true and fair view of the company's activities for the past quarter.
- The cash flow report is prepared in compliance with ASX Listing Rule 19.11A.
- It is ensured that the report is authorized by the Board of Directors of Canterbury Resources Ltd.
- Australian Accounting Standards AASB 6 and AASB 107 apply to this report.
- The report reflects on the financing and cash position changes of the entity.
- The document was authorized on 30 January 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$62 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 8:33AM |
$0.440 |
$0.265 |
fallen by
39.77%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating cashflow positive in Q2 FY26.
- Secured first Flamingo Architecture customer.
- Cash on hand A$18.5M, no debt.
- CARR of A$26.1M, ARR stable at A$23.0M.
- Progress in regulatory compliance with CE certification.
- Focus on platform capability and market presence.
- Cost savings through restructuring and optimizations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Strategic Materials Limited (ASM) ORDINARY FULLY PAID |
Materials |
$480 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 8:33AM |
$1.855 |
$1.765 |
fallen by
4.85%
|
|
ASM - Price-sensitive ASX Announcement
Full Release
Key Points
- ASM completed an institutional placement raising approximately A$55 million.
- Net cash from operating activities was negative A$4.021 million.
- End of quarter cash and cash equivalents stood at A$69.7 million.
- Major expenses included production and staff costs, and a loan repayment.
- ASM received government grants and tax incentives.
- Future plans include expansion and strategic partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$13 |
Application for quotation of securities - 1AD
|
30 Jan 2026 8:32AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$6,965 |
Q4 2025 Toll Revenue and Traffic Update
|
30 Jan 2026 8:32AM |
$4.910 |
$4.800 |
fallen by
2.24%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- 9.5% increase in proportionate toll revenue for Q4 2025.
- Stable traffic with growth at Dulles Greenway and Chicago Skyway.
- Traffic impacted at Warnow Tunnel due to prior roadworks.
- Full-year 2025 traffic supported by growth in France.
- Toll revenue growth driven by toll increases and favorable forex rates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carnaby Resources Limited (CNB) ORDINARY FULLY PAID |
Materials |
$131 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 8:32AM |
$0.530 |
$0.475 |
fallen by
10.38%
|
|
CNB - Price-sensitive ASX Announcement
Full Release
Key Points
- Carnaby Resources Limited's quarterly update for 31 December 2025.
- Significant developments at Greater Duchess Copper Gold Project.
- Updated Mineral Resource Estimate with significant increases.
- Pre-Feasibility Study nearing completion, targeting production in H2 2026.
- High-grade assay results from Trekelano Prospect.
- Acquisition of remaining interest in Greater Duchess Joint Venture.
- Conducted $12.5 million placement to QIC Critical Minerals and Battery Technology Fund.
- Cash position at quarter end was $16.0 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fat Prophets Global Contrarian Fund Limited (FPC) ORDINARY FULLY PAID |
Financials |
$42 |
Weekly NAV
|
30 Jan 2026 8:31AM |
$1.640 |
$1.480 |
fallen by
9.76%
|
|
| Ironbark Balanced Income Limited (IBC) ORDINARY FULLY PAID |
Financials |
$44 |
Update - Notification of buy-back - IBC
|
30 Jan 2026 8:31AM |
$0.440 |
$0.435 |
fallen by
1.14%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,783 |
Net Tangible Asset Backing
|
30 Jan 2026 8:31AM |
$4.350 |
$4.390 |
risen by
0.92%
|
|
| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$1,514 |
Nine accelerates strategic transformation
|
30 Jan 2026 8:31AM |
$1.090 |
$0.955 |
fallen by
12.39%
|
|
NEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Nine acquires QMS Media for $850 million.
- Sale of radio assets to Laundy Family Office for $56 million.
- Conversion of NBN to an affiliate under WIN Network.
- Growth assets expected to contribute over 60% of revenue by FY27.
- Strategic focus on digital expansion and revenue diversification.
- Projected EPS accretive impact from strategic initiatives.
- Enhanced shareholder value and reduced broadcast exposure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nexus Minerals Limited (NXM) ORDINARY FULLY PAID |
Materials |
$36 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 8:30AM |
$0.073 |
$0.059 |
fallen by
19.18%
|
|
NXM - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade drilling results from Wallbrook Gold Project.
- Cash on hand at the end of the quarter is $7.8 million.
- Significant exploration progress in Crusader-Templar and other prospects.
- Discussions with potential operational and toll treatment partners are ongoing.
- Permitting and operational readiness for Crusader-Templar are advancing.
- Net cash outflow from operating activities is $1.73 million.
- Focus on systematic infill and extensional drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Taiton Resources Limited (T88) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 8:30AM |
$0.155 |
$0.060 |
fallen by
61.29%
|
|
T88 - Price-sensitive ASX Announcement
Full Release
Key Points
- E-PEPR applications approved by the Department for Energy and Mining, South Australia.
- Drilling completed at the Challenger West project.
- Drilling at Highway project scheduled for 1st quarter of 2026.
- Placement of new ordinary shares raised $2 million.
- Conversion of shareholder's loan to shares.
- Net cash from operating activities was a negative $338,000.
- Total cash and cash equivalents at quarter end were $629,000.
- Unused financing facilities of $1,000,000 available at quarter end.
- Capital raising involved issuing 33,408,000 new shares at $0.06 each.
- Appointment of Mr Shane Tomlinson as Executive Technical Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$228 |
Quarterly Cashflow Report
|
30 Jan 2026 8:29AM |
$0.034 |
$0.028 |
fallen by
17.65%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities: $2.874 million.
- Exploration and evaluation expenses: $1.213 million.
- Financing activities generated: $9.110 million.
- Cash and cash equivalents at quarter end: $5.743 million.
- Estimated 1.41 quarters of funding available.
- Additional funding of ZAR23.6 million from IDC for Flat Mines.
- Glencore financing arrangements for US$200M - US$250M in progress.
- $A10M Early Funding Arrangement with Triple Flag for Prieska Mine.
- Report prepared according to ASX Listing Rules and Australian Accounting Standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$228 |
Quarterly Activities Report
|
30 Jan 2026 8:29AM |
$0.034 |
$0.028 |
fallen by
17.65%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of due diligence for Glencore offtake and financing.
- Operational readiness and value engineering at Prieska Copper Zinc Mine.
- First concentrate from PCZM targeted by Christmas 2026.
- Exploration advancements at Okiep Copper Project.
- No safety incidents reported; high standards of environmental compliance maintained.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$9 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 8:29AM |
$0.014 |
$0.011 |
fallen by
21.43%
|
|
ENL - Price-sensitive ASX Announcement
Full Release
Key Points
- Record total contract value of A$4.3m in Q4 FY25.
- 16 new client agreements executed in Q4 FY25.
- Completed capital raise of A$2.6m; additional A$5.4m subject to approval.
- Net operating cash outflow of US$3.3m for the quarter.
- Cash balance of US$2.57m at the end of December 2025.
- Implemented cost reduction measures for US$2.5m in annual savings.
- Revenue impacted by expanded project scopes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NOVONIX Limited (NVX) ORDINARY FULLY PAID |
Information Technology |
$220 |
Application for quotation of securities - NVX
|
30 Jan 2026 8:29AM |
$0.390 |
$0.255 |
fallen by
34.62%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$69 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 8:28AM |
$0.130 |
$0.135 |
risen by
3.85%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia ended the December 2025 quarter with AUD 31.5 million in cash.
- Net operating cash inflows for the quarter were AUD 2.4 million.
- Received AUD 3.8 million from government grants and tax incentives.
- Operating outflows included AUD 0.9 million for staff and administration costs.
- ACCENT trial showed a 35% response rate with narmafotinib.
- AMPLICITY trial initiated to explore narmafotinib with FOLFIRINOX.
- Positive FDA feedback on dosage optimization for narmafotinib.
- Granted a key patent for narmafotinib.
- Listed on the US-based OTCQB Venture Market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
